Skip to main
XYL

Xylem (XYL) Stock Forecast & Price Target

Xylem (XYL) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 44%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Xylem demonstrated robust financial performance in 2025, generating $9 billion in revenue and showcasing a 7% organic revenue growth in the third quarter, which reflects effective backlog execution amid resilient demand. The company's ability to maintain margin expansion, specifically 200 basis points in Q3, combined with anticipated mid-single-digit organic growth in the Measurement and Control Solutions (M&CS) segment for 2026, underscores its operational efficiency and competitive positioning in the water technology market. Xylem's presence in over 150 countries, supported by strong demand in the U.S. commercial end market, further solidifies its outlook for sustained growth and market resilience.

Bears say

Xylem's financial outlook appears negative due to a reported decline in EPS guidance for 2026, which was slightly below consensus, resulting in an immediate stock sell-off of 8%. Continued economic headwinds, particularly in China, are adversely affecting key segments like Water Infrastructure and Applied Water, with expected low single-digit revenue declines in 1Q26 compounded by local competitive pressures. Additionally, there are concerns regarding the slow ramp-up of funding for the UK's AMP 8 cycle and the variability of project timing, which may dampen growth and profitability amid the cyclical nature of the markets in which Xylem operates.

Xylem (XYL) has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 44% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Xylem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Xylem (XYL) Forecast

Analysts have given Xylem (XYL) a Buy based on their latest research and market trends.

According to 9 analysts, Xylem (XYL) has a Buy consensus rating as of Mar 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $157.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $157.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Xylem (XYL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.